{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:57:39Z","timestamp":1776329859819,"version":"3.50.1"},"reference-count":8,"publisher":"Baskent University","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.6002\/ect.2025.0117","type":"journal-issue","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T07:13:47Z","timestamp":1757402027000},"source":"Crossref","is-referenced-by-count":0,"title":[],"prefix":"10.6002","volume":"23","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Mazzaferro V, Pulvirenti A, Coppa J. Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation? J Hepatol. 2007;47(4):460-466. doi:10.1016\/j.jhep.2007.07.004","DOI":"10.1016\/j.jhep.2007.07.004"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Valvi D, Mei X, Gupta M, et al. Younger age is associated with improved survival in patients undergoing liver transplantation alone for metastatic neuroendocrine tumors. J Gastrointest Surg. 2021;25(6):1487-1493. doi:10.1007\/s11605-020-04708-1","DOI":"10.1007\/s11605-020-04708-1"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Moris D, Tsilimigras DI, Ntanasis-Stathopoulos I, et al. Liver transplantation in patients with liver metastases from neuroendocrine tumors: a systematic review. Surgery. 2017;162(3):525-536. doi:10.1016\/j.surg.2017.05.006","DOI":"10.1016\/j.surg.2017.05.006"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Sposito C, Droz dit Busset M, Citterio D, Bongini M, Mazzaferro V. The place of liver transplantation in the treatment of hepatic metastases from neuroendocrine tumors: pros and cons. Rev Endocr Metab Disord. 2017;18(4):473-483. doi:10.1007\/s11154-017-9439-7","DOI":"10.1007\/s11154-017-9439-7"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Engels EA, Pfeiffer RM, Fraumeni JF, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011;306(17):1891-1901. doi:10.1001\/jama.2011.1592","DOI":"10.1001\/jama.2011.1592"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. \u00c5berg F, Pukkala E, H\u00f6ckerstedt K, Sankila R, Isoniemi H. Risk of malignant neoplasms after liver transplantation: a population-based study. Liver Transpl. 2008;14(10):1428-1436. doi:10.1002\/lt.21475","DOI":"10.1002\/lt.21475"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Dhillon MS, Rai JK, Gunson BK, Olliff S, Olliff J. Post-transplant lymphoproliferative disease in liver transplantation. Br J Radiol. 2007;80(953):337-346. doi:10.1259\/bjr\/63272556","DOI":"10.1259\/bjr\/63272556"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Rodr\u00edguez-Per\u00e1lvarez M, Colmenero J, Gonz\u00e1lez A, et al. Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation. Am J Transplant. 2022;22(6):1671-1682. doi:10.1111\/ajt.17021","DOI":"10.1111\/ajt.17021"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T07:27:36Z","timestamp":1757402856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/archive\/2025\/23\/8\/0\/560\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":8,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2025.0117","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}